ATRA
Atara Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.50
-0.40 ▼ -5.80%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$6.45
-0.05 ▼ -0.77%
| Index | - | P/E | 2.97 | EPS (ttm) | 2.19 | Insider Own | 41.12% | Shs Outstand | 0.01B | Perf Week | 25.73% |
| Market Cap | 0.05B | Forward P/E | 30.48 | EPS next Y | -92.56% | Insider Trans | -2.96% | Shs Float | 0.00B | Perf Month | 41.61% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | -0.18 | Inst Own | 28.6% | Short Float | 7.78% | Perf Quarter | -61.38% |
| Income | 0.02B | P/S | 0.31 | EPS this Y | 125.12% | Inst Trans | 2.61% | Short Ratio | 0.74 | Perf Half Y | -46.55% |
| Sales | 0.15B | P/B | - | EPS next 5Y | - | ROA | 27.07% | Short Interest | 0.33M | Perf YTD | -64.07% |
| Book/sh | -5.08 | P/C | 3.42 | EPS past 3/5Y | -46.45% -15% | ROE | - | 52W High | -66.05% ($19.15) | Perf Year | -5.25% |
| Cash/sh | 1.9 | P/FCF | - | Sales past 3/5Y | 85.07% - | ROIC | 226.16% | 52W Low | 65.82% ($3.92) | Perf 3Y | -91.67% |
| Dividend Est. | - | EV/EBITDA | 2.29 | EPS Y/Y TTM | 108.66% | Gross Margin | 81.63% | Volatility(W/M) | 18.98% 12.89% | Perf 5Y | -98.46% |
| Dividend TTM | - | EV/Sales | 0.6 | Sales Y/Y TTM | 51.27% | Oper. Margin | 24.74% | ATR (14) | 0.79 | Perf 10Y | -98.43% |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | EPS Q/Q | 89.19% | Profit Margin | 15.4% | RSI (14) | 56.18 | Recom | 2.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.02 | Sales Q/Q | -91.41% | SMA20 | 24.49% ($5.22) | Beta | -0.5 | Target Price | $9.33 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -1.82% ($6.62) | Rel Volume | 0.39 | Prev Close | $6.9 |
| Employees | 153 | LT Debt/Eq | - | EPS/Sales Surpr. | 51.95% -7.45% | SMA200 | -40.78% ($10.98) | Avg Volume(3M) | 0.45M | Price | $6.5 |
| IPO | 2014/10/16 | Option/Short | No/Yes | Trades | 1569 | Volume | 171,888 | Change | -5.8% |
뉴스 로딩 중...